Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...

Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

"Increased Prevalence of Chronic Neurological Conditions and Enhanced Healthcare Infrastructure Drive Neurology Market Growth in Unexplored Markets" BOSTON, May 21, 2025 /PRNewswire/ -- ...

According to the latest study from BCC Research, "Neurology Market: A BCC Research Overview" is estimated to increase from ...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Exosome Therapeutics Market Industry Trends and Global Forecasts to 2035, by Type of Therapeutic, Target Indication, Therapeutic Area, Route of ...

Evox Therapeutics, and others are also developing novel exosome therapies Some of the key exosome therapies in the pipeline include CAP-1002, ExoFlo, Debamestrocel, PEP (Purified Exosome Product ...

Evox Therapeutics is focused on the treatment of severe rare ... Still in the discovery phase, the company is developing a pipeline of drugs leveraging the ability of exosomes to deliver drugs to ...

Evox Therapeutics Ltd, a leading exosome therapeutics company ... developed a dominant IP estate and advanced the Company’s proprietary pipeline towards the clinic. “On behalf of the Board and the ...

CRISPR Therapeutics CRSP reported second-quarter results in line with our expectations, and its pipeline candidates are continuing to make progress. Collaboration revenue totaled $70 million ...

OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of Evox ...

OXFORD, United Kingdom, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced a research collaboration and option agreement with ...